Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy [1]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 71, Issue 1, 2005, Pages 44-45

  Kuldeep, C M ^a   Mittal, A K ^a   Gupta, L K ^a   Paliwal, V K ^a   Sharma, P ^a   Garg, A ^a  

^a RNT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE;

ADULT; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DRUG PULSE THERAPY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LETTER; MALE; MEDICAL EXAMINATION; SCLEROMYXEDEMA; SKINFOLD; TREATMENT OUTCOME;

EID: 14844335038     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.13787     Document Type: Letter

References (5)

1. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37-43.
2. Harper RA, Rispler J. Lichen myxedematous serum stimulates human skin fibroblast proliferation. Science 1978;199:545-7.
3. Lister RK, Jolles S, Whitteker S, Black C, Forgacs I, Cramp M, et al. Scleromyxedema: Response to high dose intravenous immunoglobulin (hdIVIG). J Am Acad Dermatol 2000;43:403-8.
4. Pasricha JS, Thanzama J, Khan UK, Intermittent high dose dexamethasone cycloposphamide therapy for pemphigus. Br J Dermatol 1988;119:73-7.
5. Pai BS, Srinivas CR, Sabitha L. Efficacy of dexamethasone pulse therapy in progressive systemic sclerosis. Int J Dermatol 1995;34:726-8.